This includes the Wegovy pill, Foundayo, and the Ozempic pill
Also Read: Weight Loss Supplements Market Analysis & Forecast for 2025-2032 Analysts View The global anti-obesity drug industry is set to experience strong growth, owing to rising prevalence of obesity, escalating health and wellness awareness, growing popularity of combination therapies, and advancements in new drug formulations, said a senior CMI analyst
Retatrutide (investigational) Retatrutide is the newest entrant, activating three receptors: GLP-1, GIP, and glucagon
Green and clean process to obtain low degree of polymerisation xylooligosaccharides from almond shell
The launch of oral GLP-1s coupled with lower prices and broader access (including Medicare and Medicaid coverage in the U.S.) should drive higher utilization and market penetration as more affordable and convenient options become available, Schott said
How does Mounjaro affect your vision